Quant Healthcare Fund - Growth Option - Regular Plan
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 11-07-2023
AUM:
₹ 414.02 Cr
Expense Ratio
2.4%
Benchmark
BSE Healthcare TRI
ISIN
INF966L01CG3
Minimum Investment
5000.0
Minimum Topup
1000.0
Minimum SIP Amount
1000
Fund Manager
Mr. Sandeep Tandon
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Quant Healthcare Fund - Growth Option - Regular Plan | -6.78 | - | - |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
15.05
Last change
0.04 (0.2359%)
Fund Size (AUM)
₹ 414.02 Cr
Performance
21.72% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
Fund Manager
Mr. Sandeep Tandon
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| TREPS 01-Aug-2025 DEPO 10 | 11.42 |
| ASTER DM HEALTHCARE LIMITED EQ | 10.01 |
| RPG LIFE SCIENCES LIMITED EQ | 8.83 |
| ZYDUS WELLNESS LIMITED EQ | 6.36 |
| SEQUENT SCIENTIFIC LIMITED EQ NEW FV RS. 2/- | 6.21 |
| GLENMARK LIFE SCIENCES LIMITED EQ NEW FV Rs.2/- | 6.21 |
| Lupin Limited 28/08/2025 | 6.21 |
| PFIZER LIMITED EQ | 6.09 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 6.05 |
| ANTHEM BIOSCIENCES PRIVATE LIMITED EQ NEW FV Rs. 2/- | 5.94 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 67.31 |
| Fast Moving Consumer Goods | 6.36 |
| Financial Services | 5.49 |
| Telecommunication | 4.41 |